Dr. Paul Berson is a Arnold, Maryland based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Paul Berson is D0000508 for Ophthalmology in Maryland. Dr. Paul Berson is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Paul Berson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
83 Church Rd, Arnold, Maryland, 21012-2306
Phone:
772-631-9165
Fax:
253-679-5334
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1043521321
NPI Enumeration Date:
01 Jul, 2010
NPI Last Update On:
01 Jul, 2010
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Paul Berson are as mentioned below.
License Number
Specialization
State
Status
D0000508
Ophthalmology
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
923 Oyster Cove Dr, Grasonville, Maryland
Zip:
21638-1080
Phone Number:
772-631-9165
Fax Number:
253-679-5334
Patients can reach Dr. Paul Berson at 83 Church Rd, Arnold, Maryland or can call to book an appointment on 772-631-9165. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.